Cooper Companies (COO) Non-Current Deffered Revenue (2021 - 2026)

Cooper Companies' (COO) quarterly Non-Current Deffered Revenue came in at $208.8 million in Q2 2026, up 6.31% year-on-year from $196.4 million in Q2 2025, and up 1.16% quarter-over-quarter from $206.4 million in Q1 2026.

Cooper Companies (COO) Non-Current Deffered Revenue (2021 - 2026) Analysis & Trends

Cooper Companies' Non-Current Deffered Revenue history runs 6 years deep, the most recent figure standing at $208.8 million for Q2 2026.

  • On a quarterly basis, Non-Current Deffered Revenue rose 6.31% year-over-year to $208.8 million in Q2 2026; TTM through Apr 2026 was $208.8 million, a 6.31% increase from a year earlier, with the FY2025 full-year figure at $201.8 million, up 4.4% from the prior year.
  • Non-Current Deffered Revenue advanced to $208.8 million in Q2 2026 per COO's latest filing, from $206.4 million in the prior quarter.
  • Across five years, Non-Current Deffered Revenue topped out at $208.8 million in Q2 2026 and bottomed at $182.6 million in Q2 2023.
  • The 5-year median for Non-Current Deffered Revenue is $193.4 million (2025), against an average of $194.1 million.
  • Across the five-year window, Non-Current Deffered Revenue surged 198200.0% in 2022 and declined 7.11% in 2023, its largest moves.
  • Year by year, Non-Current Deffered Revenue stood at $198.3 million in 2022, then retreated by 7.11% to $184.2 million in 2023, then grew by 4.94% to $193.3 million in 2024, then advanced by 4.4% to $201.8 million in 2025, then climbed by 3.47% to $208.8 million in 2026.
  • Per Business Quant, the three latest COO Non-Current Deffered Revenue figures stand at $208.8 million (Q2 2026), $206.4 million (Q1 2026), and $201.8 million (Q4 2025).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non-Current Deffered Revenue (Qtr)
1 Alcon 32,734,969.19 Bn 32,734,967.53 Bn 1.53 Bn -
2 Intuitive Surgical 117.50 Bn 112.41 Bn 1.96 Bn -
3 Becton Dickinson 42.93 Bn 42.11 Bn 2.15 Bn -
4 Medline 30.82 Bn 36.66 Bn 1.84 Bn -
5 Resmed 27.90 Bn 26.23 Bn 890.98 Mn 163.15 Mn
6 West Pharmaceutical Services 26.76 Bn 26.23 Bn 329.20 Mn 13.90 Mn
7 Cooper Companies 15.30 Bn 15.16 Bn 735.40 Mn 208.80 Mn
8 Solventum 13.46 Bn 12.90 Bn 1.10 Bn -
9 Align Technology 12.02 Bn 10.96 Bn 736.59 Mn -
10 Baxter International 11.17 Bn 9.12 Bn 891.00 Mn -

Historic Data

Download Data
DateValue
Apr 30, 2026 208.80 Mn
Jan 31, 2026 206.40 Mn
Oct 31, 2025 201.80 Mn
Jul 31, 2025 199.40 Mn
Apr 30, 2025 196.40 Mn
Jan 31, 2025 193.40 Mn
Oct 31, 2024 193.30 Mn
Jul 31, 2024 190.80 Mn
Apr 30, 2024 188.60 Mn
Jan 31, 2024 186.30 Mn
Oct 31, 2023 184.20 Mn
Jul 31, 2023 185.50 Mn
Apr 30, 2023 182.60 Mn
Jan 31, 2023 195.10 Mn
Oct 31, 2022 198.30 Mn
Oct 31, 2021 100,000.00